Primary Site >> Colorectal Cancer

Gene >> SDC1

  • 1996
  • 1997
  • 1999
  • 2001
  • 2002
  • 2004
  • 2005
  • 2006
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes.
PMID: 8695359
Ref: Several carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity proteins.
PMID: 9151893
Ref: [Oncogenic activation of p21ras or pp60c-src in human colonic Caco-2 cells induces post-translation alterations of syndecan-1].
PMID: 9207867
Ref: Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence.
PMID: 10071246
Ref: Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma.
PMID: 10389767
Ref: Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
PMID: 11520060
Ref: Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.
PMID: 11676858
Ref: Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells.
PMID: 12055189
Ref: Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.
PMID: 15177497
Ref: Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer.
PMID: 16020957
Ref: [Unique case of caecum plasmablastic lymphoma CD138(+) in patient with late diagnosed colon neuroendocrine carcinoma].
PMID: 16773592
Ref: Heparanase-2 and syndecan-1 in colon cancer: the ugly ducklings or the beautiful swans?
PMID: 18528290
Ref: Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.
PMID: 18617780
Ref: An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1.
PMID: 19253033
Ref: YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.
PMID: 19767768
Ref: Expression and clinical significance of syndecan-1 mRNA and HPA-1 mRNA in colorectal cancer detected with real-time fluorescent quantitative polymerase chain reaction.
PMID: 20193112
Ref: Primary acantholytic squamous cell carcinoma of the cecum: a case report.
PMID: 21223553
Ref: EZH2 depletion blocks the proliferation of colon cancer cells.
PMID: 21765901
Ref: Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
PMID: 22034888
Ref: Role of high definition colonoscopy in colorectal adenomatous polyp detection.
PMID: 22046088
Ref: Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis.
PMID: 22071959
Ref: The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells.
PMID: 22227189
Ref: Association of syndecan-1 with angiogenesis-related markers, extracellular matrix components, and clinicopathological features in colorectal carcinoma.
PMID: 22993347
Ref: Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.
PMID: 23700897
Ref: Carbohydrate-containing molecules as potential biomarkers in colon cancer.
PMID: 24502776
Ref: High expression of CASK correlates with progression and poor prognosis of colorectal cancer.
PMID: 24927672
Ref: Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer.
PMID: 25321193
Ref: The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.
PMID: 25504222
Ref: Surface profiles of live colorectal cancer cells and tumor infiltrating lymphocytes from surgical samples correspond to prognostic categories.
PMID: 25445327
Ref: Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases.
PMID: 25589885
Ref: Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.
PMID: 25686828
Ref: Proteoglycans as potential microenvironmental biomarkers for colon cancer.
PMID: 25715761
Ref: Trans-regulation of Syndecan Functions by Hetero-oligomerization.
PMID: 25979339
Ref: Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.
PMID: 26482785
Ref: Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis.
PMID: 26518017
Ref: Syntenin controls migration, growth, proliferation, and cell cycle progression in cancer cells.
PMID: 26539120
Ref: Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
PMID: 27074317
Ref: Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/beta-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
PMID: 27127133
Ref: Local inflammatory response in colorectal cancer.
PMID: 27543872
Ref: Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma.
PMID: 28350804
Ref: Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cgamma-mediated FAK/ERK signaling pathway in colon cancer.
PMID: 28821612
Ref: Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
PMID: 30027065